COVID-19 / Medicines for Europe Leadership Team on Generics Industry Response & European Pharma Reform
In conversation with PharmaBoardroom Christoph Stoller and Adrian Van den Hoven of Medicines for Europe, the…
Patrick Burton |
Editor
Patrick is an editor at PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 30 country reports and is a fluent Mandarin speaker.
Articles: Patrick Burton
Cell & Gene Therapy Launches / Zolgensma® in Belgium: Lessons Learned
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…
AMR / New Billion Dollar Pharma Action Fund to Counter ‘Slow Tsunami’ of Antimicrobial Resistance
June 9th 2020 saw the launch of a new action fund on antimicrobial resistance (AMR), with 23 leading…
GSK / Senior VP for Vaccines R&D on COVID-19 Collaboration
GSK, the world’s largest manufacturer of vaccines, has pursued a different strategy to that of its contemporaries…
Pharma Faces / Veronique Walsh, BMS Benelux
Veronique Walsh, general manager of Bristol Myers Squibb for Belgium, the Netherlands, and Luxembourg (Benelux),…
Merck KGaA / Big-Ticket Investments in Manufacturing Scale & Digital Innovation
Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number…
US Generics / Company Culture Key to Attracting Talent
Two leading executives in the US generics market outline why robust company culture is key to attracting top talent…
SCM Lifescience / A Global Approach to Korean Regenerative Medicine
Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in…
BIO 2020 / The FDA’s COVID-19 Shakeup
In a recent virtual town hall meeting hosted by BIO, two key leaders from the US FDA laid out how their…
Rare Diseases / Korean Corestem Targets US Market for Ground-Breaking ALS Treatment
After failing to attain reimbursement for its Amyotrophic Lateral Sclerosis (ALS) treatment NEURONATA-R® in Korea,…
M&A / Menarini Makes Big US Oncology Move with Stemline Acquisition
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US…
Pharma Faces / Bae Byoungjun, KoNECT, Korea
With over 30 years of experience in public office working in public health and pharmaceutical policy, food and drug…